Angela Hu
University of British Columbia(CA)Sanofi (United States)(US)
Publications by Year
Research Areas
Vasculitis and related conditions, Ubiquitin and proteasome pathways, Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Chemical Synthesis and Analysis
Most-Cited Works
- → Perforin-dependent CD4+T-cell cytotoxicity contributes to control a murine poxvirus infection(2012)88 cited
- → Perturbation of the c-Myc–Max Protein–Protein Interaction via Synthetic α-Helix Mimetics(2015)88 cited
- → Pharmacophore identification of c-Myc inhibitor 10074-G5(2012)78 cited
- → A Gene Mutation Signature Predicting Immunotherapy Benefits in Patients With NSCLC(2020)61 cited
- → Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5(2013)56 cited
- → Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids(2015)55 cited
- → <p>Neural network and logistic regression diagnostic prediction models for giant cell arteritis: development and validation</p>(2019)54 cited
- → Discovery of Methyl 4′‐Methyl‐5‐(7‐nitrobenzo[c][1,2,5]oxadiazol‐4‐yl)‐[1,1′‐biphenyl]‐3‐carboxylate, an Improved Small‐Molecule Inhibitor of c‐Myc–Max Dimerization(2014)44 cited
- → Undergraduate Dermatology Education in Canada: A National Survey(2017)32 cited
- → Information and communication needs of Chinese American breast cancer patients: perspectives on survivorship care planning(2014)32 cited